File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Production of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon

TitleProduction of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon
Authors
KeywordsCOVID-19
live attenuated vaccine
replicon
SARS-CoV-2
single-cycle infectious virus
Issue Date2022
Citation
Journal of Medical Virology, 2022, v. 94, n. 12, p. 6078-6090 How to Cite?
AbstractSingle-cycle infectious virus can elicit close-to-natural immune response and memory. One approach to generate single-cycle severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is through deletion of structural genes such as spike (S) and nucleocapsid (N). Transcomplementation of the resulting ΔS or ΔN virus through enforced expression of S or N protein in the cells gives rise to a live but unproductive virus. In this study, ΔS and ΔN BAC clones were constructed and their live virions were rescued by transient expression of S and N proteins from the ancestral and the Omicron strains. ΔS and ΔN virions were visualized by transmission electron microscopy. Virion production of ΔS was more efficient than that of ΔN. The coated S protein from ΔS was delivered to infected cells in which the expression of N protein was also robust. In contrast, expression of neither S nor N was detected in ΔN-infected cells. ΔS underwent viral RNA replication, induced type I interferon (IFN) response, but did not form plaques. Despite RNA replication in cells, ΔS infection did not produce viral progeny in culture supernatant. Interestingly, viral RNA replication was not further enhanced upon overexpression of S protein. Taken together, our work provides a versatile platform for development of single-cycle vaccines for SARS-CoV-2.
Persistent Identifierhttp://hdl.handle.net/10722/335887
ISSN
2023 Impact Factor: 6.8
2023 SCImago Journal Rankings: 1.560
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCheung, Pak Hin Hinson-
dc.contributor.authorYe, Zi Wei-
dc.contributor.authorLui, Wai Yin-
dc.contributor.authorOng, Chon Phin-
dc.contributor.authorChan, Pearl-
dc.contributor.authorLee, Tak Wang Terence-
dc.contributor.authorTang, Tze Tung-
dc.contributor.authorYuen, Tin Long-
dc.contributor.authorFung, Sin Yee-
dc.contributor.authorCheng, Yun-
dc.contributor.authorChan, Ching Ping-
dc.contributor.authorChan, Chi Ping-
dc.contributor.authorJin, Dong Yan-
dc.date.accessioned2023-12-28T08:49:29Z-
dc.date.available2023-12-28T08:49:29Z-
dc.date.issued2022-
dc.identifier.citationJournal of Medical Virology, 2022, v. 94, n. 12, p. 6078-6090-
dc.identifier.issn0146-6615-
dc.identifier.urihttp://hdl.handle.net/10722/335887-
dc.description.abstractSingle-cycle infectious virus can elicit close-to-natural immune response and memory. One approach to generate single-cycle severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is through deletion of structural genes such as spike (S) and nucleocapsid (N). Transcomplementation of the resulting ΔS or ΔN virus through enforced expression of S or N protein in the cells gives rise to a live but unproductive virus. In this study, ΔS and ΔN BAC clones were constructed and their live virions were rescued by transient expression of S and N proteins from the ancestral and the Omicron strains. ΔS and ΔN virions were visualized by transmission electron microscopy. Virion production of ΔS was more efficient than that of ΔN. The coated S protein from ΔS was delivered to infected cells in which the expression of N protein was also robust. In contrast, expression of neither S nor N was detected in ΔN-infected cells. ΔS underwent viral RNA replication, induced type I interferon (IFN) response, but did not form plaques. Despite RNA replication in cells, ΔS infection did not produce viral progeny in culture supernatant. Interestingly, viral RNA replication was not further enhanced upon overexpression of S protein. Taken together, our work provides a versatile platform for development of single-cycle vaccines for SARS-CoV-2.-
dc.languageeng-
dc.relation.ispartofJournal of Medical Virology-
dc.subjectCOVID-19-
dc.subjectlive attenuated vaccine-
dc.subjectreplicon-
dc.subjectSARS-CoV-2-
dc.subjectsingle-cycle infectious virus-
dc.titleProduction of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/jmv.28057-
dc.identifier.pmid35941087-
dc.identifier.scopuseid_2-s2.0-85135876998-
dc.identifier.volume94-
dc.identifier.issue12-
dc.identifier.spage6078-
dc.identifier.epage6090-
dc.identifier.eissn1096-9071-
dc.identifier.isiWOS:000841212600001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats